SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Acutaas Chemicals informs about press release

29 Jan 2026 Evaluate
Acutaas Chemicals has informed that it enclosed newspaper publication of Standalone and Consolidated Unaudited Financial Results for the third quarter and nine months ended on December 31, 2025 published on Thursday, January 29, 2026 in Financial Express, All India editions (English) & Financial Express, Ahmedabad edition (Gujarati) newspapers.

The above information is a part of company’s filings submitted to BSE.

Acutaas Chemicals Share Price

2372.80 -38.35 (-1.59%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×